• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
YAN Qiang, WU Shumin, NI Lili, XIE Yusuo, GAO Liuzhou, HUANG Wenlong, LIU Yingjie, HU Guoqiang. Synthesis and antitumor activity of C-3 thiazolo [3, 2-b][1, 2, 4]triazole-substituted pefloxacin derivatives[J]. Journal of China Pharmaceutical University, 2015, 46(5): 548-551. DOI: 10.11665/j.issn.1000-5048.20150505
Citation: YAN Qiang, WU Shumin, NI Lili, XIE Yusuo, GAO Liuzhou, HUANG Wenlong, LIU Yingjie, HU Guoqiang. Synthesis and antitumor activity of C-3 thiazolo [3, 2-b][1, 2, 4]triazole-substituted pefloxacin derivatives[J]. Journal of China Pharmaceutical University, 2015, 46(5): 548-551. DOI: 10.11665/j.issn.1000-5048.20150505

Synthesis and antitumor activity of C-3 thiazolo [3, 2-b][1, 2, 4]triazole-substituted pefloxacin derivatives

More Information
  • To search for fluoroquinolones(FQs)with antitumor activity, the C-3 carboxylic acid group of pefloxacin( 1 )was replaced by fused heterocyclic core, and twelve novel thiazolo[3, 2-b][1, 2, 4]triazole heterocycles( 6a - 6l )were designed and synthesized. The structures of target compounds were characterized by elemental analysis and spectral data. The results of the in vitro antiproliferative effect on SMMC-7721, L1210 and HL60 cell lines showed that the title compounds exhibited more significant antitumor activity than both of the pefloxacin and the corresponding opening-ring intermediates( 5a - 5l ). Among them, the target compounds which possess a benzene ring bearing a hydroxyl group( 6e )or a fluorine atom( 6j )exhibited more potent antiproliferative effect on SMMC-7721 cells than other compounds. Therefore, the antitumor fluoroquinolones can be designed by replacing the C-3 carboxylic acid group of fluoroquinolones with the thiazolo [3, 2-b][1, 2, 4] triazole moiety.
  • [1]
    Guo ZR.Strategy of molecular drug design:pharmacophore and scaffold hopping[J].Chin J Med Chem(中国药物化学杂志),2008,18(2):147-157.
    [2]
    Mugnaini C,Pasquini S,Corelli F.The 4-quinolone-3-carboxylic acid motif as a multivalent scaffold in medicinal chemistry[J].Curr Med Chem,2009,16(14):1746-1767.
    [3]
    Peng XM,Cai GX,Zhou CH.Recent developments in azole compounds as antibacterial and antifungal agents[J].Curr Top Med Chem,2013,13(16):1963-2010.
    [4]
    Sun YS,Xu QJ,Hou LL,et al. Synthesis antitumor activity of fluoroquinolone C-3 bioisosteres(IV): s-triazole-oxadiazole methylsulfide Mannich-base derivatives[J].J China Pharm Univ(中国药科大学学报),2014,45(1):39-42.
    [5]
    Xu QJ,Hou LL,Wu ZF,et al. Synthesis antitumor activity of fluoroquinolone C-3 bioisosteres(III): s-triazole-oxadiazole methylsulfide derivatives from pefloxacin[J].J China Pharm Univ(中国药科大学学报),2013,44(6):511-514.
    [6]
    You QD,Li ZY,Huang CH,et al. Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification[J].J Med Chem,2009,52(18):5649-5661.
    [7]
    Husain A, Rashid M, Mishra R, et al. Benzimidazole bearing oxadiazole and triazolo-thiadiazoles nucleus:design and synthesis as anticancer agents[J].Bioorg Med Chem Lett,2012,22(17):5438-5444.
    [8]
    Xie YS,Gao LZ,Yan Q,et al. Synthesis and antitumor activity of fluoroquinolone C-3 isosteres(VIII):s-triazole sulfide-one thiosemicarbazone derivatives from pefloxacin[J].J China Pharm Univ(中国药科大学学报),2015,46(4):416-420.
    [9]
    Xu QJ,Hou LL,Wu XK,et al. Synthesis and antitumor activity of ciprofloquinolone bis-(C3 /C7 hydrazone)s[J].J China Pharm Univ(中国药科大学学报),2013,44(1):35-38.
  • Related Articles

    [1]CHEN Xi, JIN Liang. Research progress on sumoylation in type 2 diabetes mellitus[J]. Journal of China Pharmaceutical University, 2025, 56(1): 125-131. DOI: 10.11665/j.issn.1000-5048.2023112002
    [2]XIAO Jianqi, XU Jian, SHU Fangrong, HU Xiaofen, LIU Wenyuan, FENG Feng. Effect of Artemisia Argyi Folium ethanolic extract on blood glucose and blood lipids in diabetic mice[J]. Journal of China Pharmaceutical University, 2021, 52(1): 71-76. DOI: 10.11665/j.issn.1000-5048.20210110
    [3]MU Jinming, LIU Yue, ZHANG Fangfang, JIN Liang. Relationship between circular RNA and type 2 diabetes and its clinical application[J]. Journal of China Pharmaceutical University, 2020, 51(3): 374-378. DOI: 10.11665/j.issn.1000-5048.20200316
    [4]LI Yongrong, CHENG Tao, WANG Yongsheng, LI Qin, GAO Bo, HE Yun, BAI Yu. Effect of extract of selenium-enriched Astragalus membranaceus on insulin resistance in streptozotocin-induced diabetic rats[J]. Journal of China Pharmaceutical University, 2018, 49(6): 739-745. DOI: 10.11665/j.issn.1000-5048.20180616
    [5]DU Te, CHEN Jing, SHEN Xu. Research advances in susceptibility genes of non-alcoholic fatty liver disease and its association with type 2 diabetes[J]. Journal of China Pharmaceutical University, 2018, 49(5): 537-544. DOI: 10.11665/j.issn.1000-5048.20180504
    [6]CAO Lanjie, ZHU Kuiniu, JIANG Cuihua, GUNN ·Jordan, CHE Chun-Tao, ZHANG Jian, YIN Zhiqi. Intervention effects of the extract of Alismatis Rhizoma on streptozotocin-induced type 2 diabetic rats[J]. Journal of China Pharmaceutical University, 2017, 48(5): 601-608. DOI: 10.11665/j.issn.1000-5048.20170516
    [7]WANG Xinning, XU Bin, ZHOU Jinpei, ZHANG Huibin. Advances of anti-diabetic drugs based on new targets[J]. Journal of China Pharmaceutical University, 2015, 46(2): 141-152. DOI: 10.11665/j.issn.1000-5048.20150202
    [8]ZHONG Chunmei, MA Yan, WANG Yandong, YANG Wei, HAN Zhong, SUN Jingjing, LIN Baoqin. Effect of Danhong Huayu Koufuye combined with insulin on prevention and progression of early diabetic nephropathy in rats[J]. Journal of China Pharmaceutical University, 2013, 44(6): 568-572. DOI: 10.11665/j.issn.1000-5048.20130616
    [9]LI Chen, YUAN Linhua, MA Xueqin, LIU Xiaoquan, XI Tao. Variation of cardiovascular risk biomarkers in type 2 diabetes mellitus[J]. Journal of China Pharmaceutical University, 2013, 44(3): 257-262. DOI: 10.11665/j.issn.1000-5048.20130314
    [10]HE Bi-xia, QIAO Li-yun, PENG Jun, XIE Zhi-ping, DING Qi-long. Effects and mechanisms of mifepristone on insulin-resistant HepG 2 cells[J]. Journal of China Pharmaceutical University, 2011, 42(2): 153-159.

Catalog

    Article views PDF downloads Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return